Home Quanterix Corporation

Quanterix Corporation

Quanterix Extends Oncology Footprint with Accelerated Launch of Next Gen SP-X™ Platform and CorPlex™ Validated 10-Plex

1/10/19: Company reports the new instrument platform and highly validated CorPlex assays promise to revolutionize oncology research and drug development. The progress made since the early access program was initiated in early November 2018 with select industry leaders has validated the performance and promise of the technology, resulting in an accelerated timeline for full launch. The company is now taking orders for shipping by April 1.

Quanterix to Launch High-Sensitivity Benchtop Instrument and Assays for Multiplex Biomarker Detection

HOME Quanterix Corporation, (digitizing biomarker analysis with the goal of advancing the science of precision health), today announced it will be expanding...

Must Read

New Research Demonstrates Advantages of ExactechGPS® for Knee and Shoulder Joint Replacement

ExactechGPS is a dynamic computer-assisted technology that enhances the surgical experience with active intraoperative feedback for real-time execution in a compact and mobile system within the sterile field.

Merry X-Ray Corporation Announces Significant Shift in Their Sales and Marketing Strategies

The company will be consolidating all of their existing companies and acquisitions past and present under one strong umbrella identity: MXR The Imaging Solution Company.